Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)
Vietnam flag Vietnam · Delayed Price · Currency is VND
117,000
-1,500 (-1.27%)
At close: Oct 29, 2026

HNX:PMC Cash Flow Statement

Millions VND. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
76,38182,30580,13383,56483,41664,760
Depreciation & Amortization
17,86511,85811,43211,93812,54313,968
Other Amortization
949.15150.07----
Loss (Gain) From Sale of Assets
-546.01-4,647-9,496-19,973-14,121-8,762
Provision & Write-off of Bad Debts
9.819.8131.82-452.19-407.62250.65
Other Operating Activities
-22,656-22,968-25,378-17,783-24,712-12,664
Change in Accounts Receivable
1,877-10,770-14,356-5,5053,870-4,925
Change in Inventory
-27,226-32,811-3,87537,302-33,16718,035
Change in Accounts Payable
-24,92524,97216,4456,5647,741-6,550
Change in Other Net Operating Assets
-12,979-27,390-955.6-965.781,831-1,266
Operating Cash Flow
8,74920,70953,98194,69036,99362,847
Operating Cash Flow Growth
-52.78%-61.64%-42.99%155.97%-41.14%-22.11%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-50,233-79,641-14,754-8,012-5,318-3,962
Sale of Property, Plant & Equipment
537.31,202-175.451,253334.97
Investment in Securities
-140,500108,0007,100-13,969-130,631
Other Investing Activities
20.445,98510,14419,39211,8347,473
Investing Cash Flow
-49,67668,046103,39018,656-6,200-126,785

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-20,181----
Long-Term Debt Repaid
--20,000----
Net Debt Issued (Repaid)
59,362181.01----
Common Dividends Paid
-43,102-108,457-110,542-137,548-22,770-21,655
Dividends Paid
-43,102-108,457-110,542-137,548-22,770-21,655
Financing Cash Flow
16,260-108,276-110,542-137,548-22,770-21,655

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1.281.282.371.080.99-3.61
Net Cash Flow
-24,665-19,52046,832-24,2018,024-85,596

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-41,484-58,93239,22786,67831,67558,885
Free Cash Flow Growth
---54.74%173.65%-46.21%-17.07%
Free Cash Flow Margin
-7.34%-10.78%7.87%17.87%6.71%14.21%
Free Cash Flow Per Share
-4445.09-6314.624203.239287.653394.026309.63
Levered Free Cash Flow
3,238-32,63438,747104,28537,57365,033
Unlevered Free Cash Flow
5,467-32,44538,747104,28537,57365,033

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
22,59519,71421,42120,58120,90313,523
Change in Working Capital
-63,254-45,998-2,74237,396-19,7265,294